Metabolize Inc

Metabolize Inc is a Saint Petersburg-based wellness company focused on developing daily oral supplements that enhance weight management and overall health, leveraging scientific research to support metabolic processes. Metabolize Inc, founded in 2024 in the United States, specializes in the health supplement sector. The company has completed one deal as of August 1, 2025, indicating its early stages in securing investment, which has positioned it for potential growth in the market. The founder's background isn't specified in the available information.

Metabolize's core offering is a daily oral supplement designed to support healthy weight management and overall wellness. This innovative capsule works by complementing a balanced diet and an active lifestyle, aiding in the maintenance of normal blood sugar levels and fostering sustainable metabolic health. The supplement is formulated with research-backed ingredients that promote metabolic support, leveraging the body’s natural chemistry to address weight management challenges. Targeting individuals seeking effective solutions for weight reduction and obesity, Metabolize's products are positioned primarily within North America and Europe, appealing to health-conscious consumers and those affected by metabolic disorders.

Metabolize generates revenue through direct-to-consumer transactions, emphasizing the sale of its flagship oral supplement. Customers purchase the product through the company's website, often utilizing a subscription model that ensures ongoing delivery. This transactional structure allows for predictable revenue streams while fostering customer loyalty through convenience. Pricing plans are structured to incentivize long-term purchases, potentially offering discounts for bulk orders or extended subscriptions.

Metabolize also explores partnerships with health and wellness retailers to expand its reach, further diversifying its revenue channels within the growing functional supplement market. In August 2025, Metabolize Inc raised an undisclosed amount in Seed funding from new investor SOSV. This funding is anticipated to support the development of new products aimed at enhancing their current supplement line. The company is also focusing on expanding into additional markets, particularly targeting regions in Europe and expanding their footprint in North America.

The strategic use of recent funding will facilitate entry into these markets, potentially increasing brand awareness and customer reach.